Noureddine Berka, Ph.D., F(ACHI)

Dr. Noureddine Berka is a senior Histocompatibility Laboratory Director at both ARC Philadelphia and Charlotte HLA laboratories and is a Clinical Professor of Pathology and Laboratory Medicine, University of Calgary.  The HLA laboratory provide comprehensive and state-of-the-art HLA services supporting hematopoietic cell transplantation (HCT), Solid Organ Transplantation, Transfusion, Disease/Drug Association Study, Vaccine research, and supports multiple clinical trials.

Dr. Noureddine Berka obtained a Master and a PhD in Genetics and Human Genetics from Howard University in Washington DC, and pursued postdoctoral clinical fellow at the University of Maryland Medical System, Baltimore, Maryland. He is board certified by the American Board of Histocompatibility and Immunogenetics and is certified by the American Society of Histocompatibility and Immunogenetics as laboratory director.  He is also certified by New York State.  Dr Berka has over 30 years of experience in HLA/Histocompatibility, has previously served as an ASHI board member and in the ASHI accreditation review board as commissionaire. He is the past chair of ASHI DTRC, and is an active ASHI inspector. Dr. Berka’s research focuses particularly on Immunology of solid organ and stem cell transplant, platelet matching, the role of host immunogenetics in diseases, and the characterization of HLA polymorphism and population genetics studies. Dr. Berka has published numerous articles in professional journals. He has been invited to speak on his research at universities and conferences throughout the U.S. and abroad.  Dr Berka is a member of many National and International professional organizations. Dr Berka has established multiple HLA/Histocompatibility laboratories in the US and Canada.